This investment case for a quality improvement programme to reduce harm caused by clinical deterioration was prepared for the Health Quality & Safety Commission by Sapere Research group.
The Commission convened a group of experts and stakeholders in late 2014 to assist with developing the investment case. Sapere interviewed additional stakeholders after the workshop.
Attachments
Relevant pages
Published: 13 Dec 2021
Modified: 13 Dec 2021
